Ameren Illinois Company
Ameren Illinois Company Fundamental Analysis
Ameren Illinois Company (AILLN) shows moderate financial fundamentals with a PE ratio of 20.80, profit margin of 16.55%, and ROE of 11.48%. The company generates $0.8B in annual revenue with strong year-over-year growth of 15.43%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 43.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze AILLN's fundamental strength across five key dimensions:
Efficiency Score
WeakAILLN struggles to generate sufficient returns from assets.
Valuation Score
ModerateAILLN shows balanced valuation metrics.
Growth Score
ExcellentAILLN delivers strong and consistent growth momentum.
Financial Health Score
WeakAILLN carries high financial risk with limited liquidity.
Profitability Score
WeakAILLN struggles to sustain strong margins.
Key Financial Metrics
Is AILLN Expensive or Cheap?
P/E Ratio
AILLN trades at 20.80 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, AILLN's PEG of 6.80 indicates potential overvaluation.
Price to Book
The market values Ameren Illinois Company at 2.26 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.82 times EBITDA. This is generally considered low.
How Well Does AILLN Make Money?
Net Profit Margin
For every $100 in sales, Ameren Illinois Company keeps $16.55 as profit after all expenses.
Operating Margin
Core operations generate 23.03 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.48 in profit for every $100 of shareholder equity.
ROA
Ameren Illinois Company generates $3.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ameren Illinois Company generates strong operating cash flow of $314.33M, reflecting robust business health.
Free Cash Flow
Ameren Illinois Company generates weak or negative free cash flow of $-75.09M, restricting financial flexibility.
FCF Per Share
Each share generates $-2.95 in free cash annually.
FCF Yield
AILLN converts -2.60% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
20.80
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
6.80
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.26
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.50
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.48
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.66
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How AILLN Stacks Against Its Sector Peers
| Metric | AILLN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 20.80 | 19.51 | Neutral |
| ROE | 11.48% | 940.00% | Weak |
| Net Margin | 16.55% | 9081.00% | Weak |
| Debt/Equity | 1.48 | 1.73 | Neutral |
| Current Ratio | 0.66 | 1.48 | Weak Liquidity |
| ROA | 3.00% | -169.00% (disorted) | Weak |
AILLN outperforms its industry in 0 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ameren Illinois Company's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
38.67%
Industry Style: Defensive, Dividend, Income
High GrowthEPS CAGR
52.64%
Industry Style: Defensive, Dividend, Income
High GrowthFCF CAGR
77.28%
Industry Style: Defensive, Dividend, Income
High Growth